4G Clinical announced its recognition as the Bio Supply Management Alliance (BSMA) Supply Chain Management Excellence and Innovation Award 2019 recipient for its utilization of natural language processing (NLP) to turn study parameters into detailed forecasts.
4G Clinical's forecasting engine, which is fully integrated with its Randomization and Trial Supply Management (RTSM) system, provides a dynamic capability for clinical supply professionals.
"Recognizing the need for innovation beyond site and depot forecasting, the innovation utilizes NLP to turn study parameters from plain English into detailed forecasts. This demand-driven solution has addressed the formidable challenge of drug development to achieve greater efficacy," said BSMA Executive Director, Devendra Mishra.
"Clinical trials today can have unpredictable enrollment and study design changes which increases supply chain complexity," Jan Pieter Kappelle, Vice President, Strategy, 4G Clinical said. "Clinical supply planners should be able to modify supply models as frequently as needed without effort, with full transparency into inputs and a direct correlation to its outputs. We are honored to be receive this prestigious award."